A significant investment of $2.1 million AUD has been made by the Australian Government's Critical Technologies Challenge Program to develop a quantum-enabled "brain-on-chip" platform, led by the University of Melbourne. This innovative project aims to harness the power of quantum computing to accelerate the discovery of treatments for neurological diseases, including Alzheimer's, epilepsy, and schizophrenia. By integrating 3D neural cell cultures with quantum-based sensing and analysis, researchers hope to create a more accurate and efficient platform for screening potential therapies. The "brain-on-chip" platform has the potential to revolutionize the field of neurological research, enabling scientists to better understand the complex interactions between neurons and test new treatments in a highly controlled environment1. The project's success could lead to breakthroughs in the development of effective treatments for these devastating diseases. The use of quantum computing in this context is particularly notable, as it allows for the analysis of complex biological systems in ways that traditional computing methods cannot. This cutting-edge research has the potential to greatly improve our understanding of neurological diseases and accelerate the development of new treatments, making it a crucial area of study for researchers and practitioners in the field. So what matters most to practitioners is that this project could ultimately lead to more effective and targeted treatments for neurological diseases, improving the lives of millions of people worldwide.